Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

George M Jenkins

Director at Palvella Therapeutics, Inc. (PVLA)

Purchase track record

Below average. Based on 2 purchases with a full 90 days of price history.

39
Avg. 90-day return+5.9%
vs. S&P 500-6.6%
Beat the market50%
Paper profit on buys+$67K
Total bought / sold$550K / $4.2M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 15SEC PVLAPalvella Therapeutics, Inc. Sell Plan 6,520181,096 held (−3%) $150.62 $982K -7.9%
Sep 15SEC PVLAPalvella Therapeutics, Inc. Sell Plan 4,577176,519 held (−3%) $151.72 $694K -8.5%
Sep 15SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,274175,245 held (−1%) $153.06 $195K -9.3%
Sep 15SEC PVLAPalvella Therapeutics, Inc. Sell Plan 5,632169,613 held (−3%) $151.46 $853K -8.4%
Sep 15SEC PVLAPalvella Therapeutics, Inc. Sell Plan 6,160163,453 held (−4%) $152.12 $937K -8.8%
Sep 15SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,560161,893 held (−1%) $153.10 $239K -9.4%
Sep 15SEC PVLAPalvella Therapeutics, Inc. Sell Plan 954160,939 held (−1%) $149.38 $143K -7.1%
Sep 15SEC PVLAPalvella Therapeutics, Inc. Sell Plan 263160,676 held (−0%) $150.40 $40K -7.7%
Sep 15SEC PVLAPalvella Therapeutics, Inc. Sell Plan 560160,116 held (−0%) $151.33 $85K -8.3%
Apr 1SEC PVLAPalvella Therapeutics, Inc. Buy 445187,616 held (+0%) $112.30 $50K +23.6%
Mar 2SEC PVLAPalvella Therapeutics, Inc. Buy 4,000187,171 held (+2%) $125.00 $500K +11.0%
  • Sell

    Director George M Jenkins sold $982K of PVLA at $150.62 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director George M Jenkins sold $694K of PVLA at $151.72 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director George M Jenkins sold $195K of PVLA at $153.06 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director George M Jenkins sold $853K of PVLA at $151.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director George M Jenkins sold $937K of PVLA at $152.12 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director George M Jenkins sold $239K of PVLA at $153.10 — pre-scheduled 10b5-1 plan sale.